Unverified50% confidenceFactExact time
The funds from this round will be used primarily to accelerate Enveda's AI-discovered natural-product-based drugs into clinical trial stages.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
9/23/2026
First Seen
Valid until: 12/22/2026
Sources
Related Entities
Related Claims
UnverifiedAIDD (AI-assisted drug discovery and development) is the direction with the highest salary ceiling in pharmaceutical AI, with primary work including target identification, virtual screening, and molecular generation and optimization.66% similarUnverifiedThe demand for computing power in AI drug discovery and precision medicine is growing exponentially.64% similarUnverifiedAI has entered pharmaceutical segments including drug discovery, molecular screening, formulation development, real-world research, and pharmacovigilance.64% similarUnverifiedSome research groups have begun vigorously promoting automated AI-assisted scientific research, especially in the experimental phase.63% similarUnverifiedWithin generative AI investment, the foundational model layer (e.g., OpenAI, Anthropic) has attracted the largest amount of capital, but competitive barriers are extremely high.62% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/945083API
curl https://kongchang.com/api/v1/knowledge/claims/945083MCP
get_claim(id=945083)